Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes

Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes: A Randomized Controlled Trial

The purpose of this research study is to look at the effect of programs aimed at helping people manage chronic pain and medication treatment. The program sessions focus on educational information and strategies for pain and medication management. The researchers enroll people who have chronic pain and have recently begun buprenorphine treatment to see if participants could benefit from these programs. This research study will help the researchers learn how to improve current therapies for pain and medication management.

Inclusion Criteria:

• having a diagnosis of an opioid use disorders (OUD) within the past 12 months;
• started buprenorphine (the term we use to refer to all buprenorphine products including buprenorphine/naloxone) treatment within the past 6 months
• at least moderate or greater self-reported pain on average over the past 3 months;
• regular and consistent access to a telephone and willingness to use the phone for study sessions.

Exclusion Criteria:

• buprenorphine medication prescribed in the form of a monthly injection and/or a transdermal patch
• self-reported pregnancy at the time of study enrollment
• currently living outside of the United States